Article Details

Development of NK cell-based cancer immunotherapies through receptor engineering

Retrieved on: 2024-03-05 14:23:31

Tags for this article:

Click the tags to see associated articles and topics

Development of NK cell-based cancer immunotherapies through receptor engineering. View article details on hiswai:

Excerpt

Indeed, the addition of monoclonal antibodies can potentiate NK-mediated ADCC. Allogeneic NK cells were tested in combination with the anti-CD20 ...

Article found on: www.nature.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up